×

Access Whitepaper

First Name
Last Name
Company
Thank you!
Error - something went wrong!
   

Part 3: Evaluating Study Status and Leveraging Data Monitoring Committees to Make Study Decisions

May 14, 2020

Our panelists discuss best practices for:

  • Evaluating whether there is enough reliable data to draw meaningful clinical study conclusions
  • Assessing the status of each clinical study – what challenges and opportunities are presented based on study characteristics and timeline?
  • Determining how studies can be designed now to build in future flexibility in schedules, procedures and analysis plans
  • Leveraging DMCs/DSMBs to play a role in the assessment and modification of studies
  • Revisiting safety data collection and reporting during the COVID-19 crisis
Previous Flipbook
Part 4: Planning for Recovery: How Research Sponsors and Research Sites are Thinking Ahead to Restart Research
Part 4: Planning for Recovery: How Research Sponsors and Research Sites are Thinking Ahead to Restart Research

Next Flipbook
Part 2: The Necessary Changes that Sites, Institutions and Research Participants are Considering During the COVID-19 Crisis
Part 2: The Necessary Changes that Sites, Institutions and Research Participants are Considering During the COVID-19 Crisis

Request a Genetics in Clinical Trials training session

What You'll Learn